◼ Archived
Business
🔮 Newsylist predicts: fades by tomorrow high confidence — graded ✓ correct
A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs
12sources
13articles
11velocity
+0%since first seen
5d agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The reporting (13)
- Medical Moment: What to know about the newly approved drug to treat pancreatic cancer WKRG · 4d ago
- Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug University of Cincinnati · 4d ago
- Cancer Center Aids Key Trials for New Pancreatic Drug Mirage News · 4d ago
- New pancreatic cancer pill priced at $480,000 per year KTLA · 4d ago
- FDA approves new drug Rasonque to treat advanced pancreatic cancer France 24 · 5d ago
- 6 Cancer Drugs FDA Approved in August 2026 and What They Mean for You Cure Today · 5d ago
- Baldwin County widower shares how his late wife helped advance cancer research WKRG · 5d ago
- Amid Rasonque Excitement, Biomarker Testing Remains Important in Pancreatic Cancer Care Precision Medicine Online · 5d ago
- The ongoing first-line treatment race for metastatic pancreatic ductal adenocarcinomas: will a tough disease lose its horror? Oncology Central · 5d ago
- St. Johnsbury woman finds hope in new pancreatic cancer drug after losing husband WCAX · 5d ago
- We’re reading about drug pricing deals, a new cancer therapy approval, and more STAT · 5d ago
- A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs NYT > Business · 5d ago
- A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugs The New York Times · 5d ago broke it first
Related trends
◼ Archived
Business
🔮 holds ✗
Bank of Canada mulls Trump tariff shock as it readies interest rates decision
Bank of Canada pauses rate hikes at 2.25% while U.S. tariff threats loom over the economy.
◼ Archived
Business
🔮 fades ✓
Uber to cut 10% of its global workforce
Uber cuts 3,300 jobs, 10% of staff, to streamline and fund its robotaxi ambition.
◼ Archived
Business
🔮 fades ✓
Breman Speech: RBNZ Governor sheds light on policy outlook after interest rate hike
New Zealand’s central bank lifts its official cash rate to 2.75%, sparking debate over the timing of future hikes.
◼ Archived
Business
🔮 holds ✗
Anthropic upgrades Claude with new Fable 5.1 model, details here
Anthropic’s Claude Fable 5.1 debut arrives with a $35 billion Lambda cloud pact and promises lower costs and sharper coding skills.
◼ Archived
Business
🔮 holds ✗
Lowe's launches major effort to help close America's skilled trades gap
Lowe’s unveils a million‑person skilled‑trades coalition as AI fuels a surge in demand.
◼ Archived
Business
🔮 holds ✗
Asian Stocks to Fall as Iran Flare-Up Boosts Oil: Markets Wrap
Iran’s flare‑up spikes oil above $91, sending Asian equities and global bonds tumbling